ATRC
Abu Dhabi’s Advanced Technology Research Council (ATRC) signed a Memorandum of Understanding (MoU) with the Ministry of Information and Telecommunications of the Republic of Serbia, and the Institute for Artificial Intelligence Research and Development of Serbia. This landmark collaboration aims to leverage the technical expertise of ATRC and its subsidiaries for integration of Artificial Intelligence (AI) into Serbia’s technological infrastructure.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240214719869/en/
His Excellency Shahab Issa Abu Shahab, Director General of ATRC, Mihailo Jovanović, Minister of Information and Telecommunications of the Republic of Serbia and Dubravko Culibrk, Director of the Institute for AI Research and Development of Serbia signed a Memorandum of Understanding on the sidelines of the World Government Summit 2024. (Photo: AETOSWire)
Under the terms of the MoU, Serbia will support the adoption of the ATRC’s Falcon large language models (LLM) and explore avenues of collaboration with ATRC around Falcon-powered solutions. Furthermore, both entities will work together to encourage organizations from Serbia to join the Falcon Foundation and contribute to the success of open-source Falcon models.
The MoU was signed by His Excellency Shahab Issa Abu Shahab, Director General of ATRC, Mihailo Jovanovic, Minister of Information and Telecommunications of the Republic of Serbia, and Dubravko Culibrk, Director of the Institute for AI Research and Development of Serbia, on the sidelines of the World Governments Summit 2024.
Expressing optimism about the alliance, His Excellency Shahab Issa Abu Shahab, Director General of ATRC said: “AI is a powerful catalyst for innovation and progress. The collaboration between ATRC, the Serbian Ministry of IT, and its Institute of AI Research and Development, marks a critical milestone as we witness an increasing global interest in adopting Falcon. Our shared commitment to the Falcon open-source models ensures a dynamic and inclusive approach to advancing AI capabilities worldwide.”
For his part, Mihailo Jovanović, Minister of Information and Telecommunications of the Republic of Serbia said, “We are taking a step further and thanks to the expertise of the Advanced Technology Research Council (ATRC), we are starting to use and apply Falcon open source models for the development of AI in Serbia. This step forward will help us in further implementation of modernization projects within the Serbia 2027 Programme and strengthen the position of Serbia as a technological and digital leader in the region of Southeast Europe.”
Dubravko Culibrk, Director of the Institute for AI Research and Development of Serbia, also remarked: “We are thrilled to embark on this transformative journey with ATRC. By integrating Falcon open-source models across the board, we aim to drive breakthroughs in AI research and development. Partnerships with governments worldwide are crucial for creating an environment where innovation flourishes, ensuring that AI becomes a driving force for positive change.”
The Falcon LLMs are a family of powerful, open-source large language models developed by the Technology Innovation Institute, ATRC’s applied research arm.
The partnership marks a significant stride in exporting Falcon’s capability at a country level beyond the Middle East, laying the groundwork for global collaborative initiatives that will shape the future of technological innovation.
Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240214719869/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kolmar Korea Named One of the TIME’s World’s Best Companies for Sustainable Growth26.12.2024 15:00:00 CET | Press release
Ranks 125th Among 500 Companies Around the GlobeTop 10% in the Environmental Sector Among 3,000 Major Global Companies Kolmar Korea (KRX: 024720) has been recognized by TIME Magazine as one of the World’s Best Companies for Sustainable Growth 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241226863828/en/ Kolmar Korea on TIME's World's Best Companies in Sustainable Growth 2025 (Image: Kolmar Korea) On November 27, TIME, in collaboration with a global market research firm Statista, unveiled a list of the top 500 companies worldwide, demonstrating exceptional sustainable growth. Kolmar Korea took place 125th around the globe and 6th among Korean companies. Notably, it was the only Korean cosmetics company on the list, which featured a total of 23 Korean companies. The rankings were based on an evaluation of revenue growth, financial stability, and environmental impact, each contributing equally to a final score out of 10
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press release
Agreement Marks Significant Step Towards Increasing Italy’s Contribution to advancing Lunar Exploration ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom